Huons Global Co. Ltd. has described reversible H+/K+ ATPase inhibitors, particularly acid pump antagonists (APA), reported to be useful for the treatment of gastric and duodenal ulcers, gastritis, gastroesophageal reflux disease, Helicobacter pylori infection and Zollinger-Ellison syndrome.